Literature DB >> 17534086

Electroconvulsive therapy: a review of history, patient selection, technique, and medication management.

Stephen Taylor1.   

Abstract

Electroconvulsive therapy (ECT) is a safe and effective treatment for severe and persistent depression, bipolar disorder and schizophrenia. Though ECT is now over 60 years old, it remains an underutilized treatment today. History, patient selection, safety, and characteristics of the treatment stimulus, technique, and medications used in ECT are reviewed. Dosing strategies, as pertaining to seizure threshold, will be considered. Mechanisms of action, especially with regard to serotonin, norepinephrine, and dopamine receptor expression will be discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534086     DOI: 10.1097/SMJ.0b013e318038fce0

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  10 in total

1.  Treating resistant depression with 2 forms of convulsive therapy: a clinical case study

Authors:  Anastasios A. Daskalakis; Zafiris J. Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

Review 2.  Anesthetic care for electroconvulsive therapy.

Authors:  Kyoung-Woon Joung; Dong Ho Park; Chang Young Jeong; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-15

3.  Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy.

Authors:  Ayse Mizrak; Senem Koruk; Suleyman Ganidagli; Mahmut Bulut; Unsal Oner
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

4.  Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

Authors:  Darrick T Balu; Brian A Hoshaw; Jessica E Malberg; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Journal:  Brain Res       Date:  2008-03-21       Impact factor: 3.252

Review 5.  Rare and very rare adverse effects of clozapine.

Authors:  Pasquale De Fazio; Raffaele Gaetano; Mariarita Caroleo; Gregorio Cerminara; Francesca Maida; Antonio Bruno; Maria Rosaria Muscatello; Maria Jose Jaén Moreno; Emilio Russo; Cristina Segura-García
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-06       Impact factor: 2.570

Review 6.  Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders.

Authors:  Rickinder Sethi; Nieves Gómez-Coronado; Adam J Walker; Oliver D'Arcy Robertson; Bruno Agustini; Michael Berk; Seetal Dodd
Journal:  Front Psychiatry       Date:  2019-09-04       Impact factor: 4.157

7.  Effects of Propofol and Propofol-Remifentanil Combinations on Haemodynamics, Seizure Duration and Recovery during Electroconvulsive Therapy.

Authors:  Canan İkiz; Ferim Günenç; Leyla İyilikçi; Şule Özbilgin; Hülya Ellidokuz; Can Cimilli; Zehra Mermi; Erol Gökel
Journal:  Turk J Anaesthesiol Reanim       Date:  2020-12-16

8.  Interaction between Neuronal Depolarization and MK-801 in SH-SY5Y Cells and the Rat Cortex.

Authors:  Yeni Kim; Miran Seo; Yun-Il Lee; So-Young Kim; Eun-Ah Cho; Se-Hyun Kim; Yong-Min Ahn; Ung-Gu Kang; Yong-Sik Kim; Yong-Sung Juhnn
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

9.  Repetitive transcranial magnetic stimulation for hallucination in schizophrenia spectrum disorders: A meta-analysis.

Authors:  Yingli Zhang; Wei Liang; Shichang Yang; Ping Dai; Lijuan Shen; Changhong Wang
Journal:  Neural Regen Res       Date:  2013-10-05       Impact factor: 5.135

10.  Medication management during electroconvulsant therapy.

Authors:  Monica Zolezzi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.